MindBio Therapeutics (MBIO) | WebDisclosure

Basculer en Français

8225	Companies
111027	Keywords
52753	Articles
60938	Press releases

Home
Companies
MindBio Therapeutics

BRIEF

published on 08/19/2024 at 13:25, 2 months 19 days ago

MindBio rapporte une réponse antidépressive soutenue après un traitement par microdosage

Essais Cliniques Microdosage Du LSD Traitement De Santé Mentale Thérapeutique MindBio Réponse Aux Antidépresseurs
BRIEF

published on 08/19/2024 at 13:25, 2 months 19 days ago

MindBio Reports Sustained Antidepressant Response Post Microdosing Treatment

Clinical Trials Microdosing LSD MindBio Therapeutics Mental Health Treatment Antidepressant Response
PRESS RELEASE

published on 08/19/2024 at 13:20, 2 months 19 days ago

MindBio Announces Sustained Antidepressant Response 3-Months Post Treatment in Microdosing Depression Clinical Trials
MindBio reports sustained antidepressant response in depressed patients three months post MB22001 treatment. Excellent safety and efficacy shown in Phase 2A clinical trials

MindBio Phase 2A Clinical Trials Antidepressant Response MB22001 Treatment Sustained
BRIEF

published on 08/01/2024 at 11:25, 3 months 7 days ago

MindBio Therapeutics nomme Haywood Securities pour un conseil en investissement stratégique

Investissement Stratégique Biopharmaceutique Santé Mentale Essais Cliniques Médecine Psychédélique
BRIEF

published on 08/01/2024 at 11:25, 3 months 7 days ago

MindBio Therapeutics Appoints Haywood Securities for Strategic Investment Advisory

Psychedelic Medicine Strategic Investment Clinical Trials Mental Health Biopharmaceutical
PRESS RELEASE

published on 08/01/2024 at 11:20, 3 months 7 days ago

MindBio Therapeutics Appoints Haywood Securities to Conduct Strategic Investment Advisory
MindBio Therapeutics appoints Haywood Securities Inc. as strategic advisor to support investment initiatives. Company progressing with Phase 2B clinical trials for psychedelic medicine MB22001

Psychedelic Medicine Clinical Trials Investment MindBio Therapeutics Haywood Securities Inc.
BRIEF

published on 07/08/2024 at 14:25, 3 months 30 days ago

MindBio Therapeutics CEO Updates Shareholders on Clinical Trials Progress

Clinical Trials Mental Health MB22001 MindBio Psychiatric Medicine
BRIEF

published on 07/08/2024 at 14:25, 3 months 30 days ago

Le PDG de MindBio Therapeutics informe les actionnaires des progrès des essais cliniques

MB22001 Santé Mentale Essais Cliniques Médecine Psychiatrique EspritBio
PRESS RELEASE

published on 07/08/2024 at 14:20, 3 months 30 days ago

Mindbio Therapeutics CEO Issues Letter To Shareholders
MindBio Therapeutics Corp. issues shareholder update on Phase 2B clinical trials progress, focusing on treating Major Depressive Disorder & Advanced Stage Cancer - End of Life Distress related Depression and Anxiety with MB22001 drug

MindBio Therapeutics Corp. Major Depressive Disorder Phase 2B Clinical Trials MB22001 Drug Advanced Stage Cancer
BRIEF

published on 06/20/2024 at 12:15, 4 months 17 days ago

MindBio Therapeutics Reports Sustained Antidepressant Response from MB22001 in Depression Clinical Trials

Depression Clinical Trials MB22001 Microdosing MindBio Therapeutics

1 2 ... 7

Accesswire

Published on 11/08/2024 at 12:00, 11 minutes ago

Fusion Energy Agreement Between RSE and BLUE LASER FUSION (USA)
Published on 11/08/2024 at 10:00, 2 hours 11 minutes ago

BluSky Carbon CEO Presents a Case for Climate Tech Optimism
Published on 11/08/2024 at 09:00, 3 hours 11 minutes ago

Greene Tweed Awarded 'Excellence in International Trade' at the 2024 East Midlands Chamber Business Awards
Published on 11/08/2024 at 07:00, 5 hours 11 minutes ago

Polaris Renewable Energy Announces Fixed Income Meetings
Published on 11/08/2024 at 03:00, 9 hours 11 minutes ago

Alset AI Appoints Wall Street Veteran and Venture Executive as President

View all ACCESSWIRE

EQS Group

Published on 11/08/2024 at 12:01, 9 minutes ago

EQS-Adhoc: Borussia Dortmund reports preliminary figures for the first quarter (Q1) of the 2024/2025 financial year
Published on 11/08/2024 at 12:01, 9 minutes ago

Original-Research: Knaus Tabbert AG (von Montega AG): Kaufen
Published on 11/08/2024 at 11:30, 41 minutes ago

Shelly Group: Invitation to unaudited 9M 2024 earnings webcast/call on 14 November 2024
Published on 11/08/2024 at 11:12, 58 minutes ago

Original-Research: Masterflex SE (von Montega AG): Kaufen
Published on 11/08/2024 at 11:10, 1 hour ago

Ossiam ESG Shiller Barclays CAPE® Global Sector UCITS ETF: notice of closure

Les Echos

Published on 11/08/2024 at 08:00, 4 hours 11 minutes ago

DAMARTEX / Droits de vote bruts et réels 31 octobre 2024
Published on 11/07/2024 at 19:00, 17 hours 11 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/07/2024 at 19:00, 17 hours 11 minutes ago

ALTAREA : DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR LA SOCIETE SUR SES PROPRES TITRES OCTOBRE 2024
Published on 11/07/2024 at 19:00, 17 hours 11 minutes ago

ALTAREIT : DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR LA SOCIETE SUR SES PROPRES TITRES OCTOBRE 2024
Published on 11/07/2024 at 19:00, 17 hours 11 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE